These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39030587)

  • 1. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece.
    Koufaki MI; Patrinos GP; Vasileiou KZ
    Hum Genomics; 2024 Jul; 18(1):82. PubMed ID: 39030587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
    Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
    BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoping review of enablers and challenges of implementing pharmacogenomics testing in the primary care settings.
    Mai CW; Sridhar SB; Karattuthodi MS; Ganesan PM; Shareef J; Lee EL; Armani K
    BMJ Open; 2024 Nov; 14(11):e087064. PubMed ID: 39500605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing pharmacogenomic testing in Australian general practice: an exploratory qualitative study.
    Ewasiuk E; Emery J; Reid G; Saya S
    Pharmacogenomics; 2024; 25(8-9):377-389. PubMed ID: 39109497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 8. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis.
    Virelli CR; Mohiuddin AG; Kennedy JL
    Transl Psychiatry; 2021 Oct; 11(1):509. PubMed ID: 34615849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
    Amara N; Blouin-Bougie J; Bouthillier D; Simard J
    Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
    Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of pharmacogenomics: Where are we now?
    Medwid S; Kim RB
    Br J Clin Pharmacol; 2024 Aug; 90(8):1763-1781. PubMed ID: 36366858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation.
    Deininger KM; Tran JN; Tsunoda SM; Young GK; Lee YM; Anderson HD; Page Ii RL; Hirsch JD; Aquilante CL
    Pharmacogenomics; 2019 Dec; 20(18):1291-1302. PubMed ID: 31755847
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
    Bright D; Worley M; Porter BL
    Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes and Awareness Toward Pharmacogenomics and Personalized Medicine Adoption Among Health Sciences Trainees: Experience from Greece and Lessons for Europe.
    Siamoglou S; Koromina M; Politopoulou K; Samiou CG; Papadopoulou G; Balasopoulou A; Kanavos A; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Mar; 25(3):190-199. PubMed ID: 33646050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice.
    Kaur G; Nwabufo CK
    Pharmacogenet Genomics; 2024 Sep; 34(7):236-245. PubMed ID: 38917295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators of the use of clinical informatics resources to facilitate pharmacogenomic implementation in resource-limited settings.
    Bosic-Reiniger J; Martin JL; Brown KE; Anderson HD; Blackburn H; Kao DP; Trinkley KE; Woodahl EL; Aquilante CL
    JAMIA Open; 2024 Dec; 7(4):ooae101. PubMed ID: 39399271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2024 Oct; 26(10):851-863. PubMed ID: 39032821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.